Related Experiment Videos

Opioid antagonist-induced regulation of organ development

Physiology & Behavior
|April 1, 1985
PubMed

Insights

Naltrexone, an opioid antagonist, altered organ development in young rats. Low doses decreased organ weight, while high doses increased it, impacting cellular content and overall growth.

Area of Science:

  • Developmental Biology
  • Pharmacology
  • Neuroscience

Background:

  • Endogenous opioid systems play a role in physiological processes.
  • Understanding their influence on organogenesis is crucial for developmental biology.

Purpose of the Study:

  • To investigate the impact of opioid receptor blockade on organogenesis in Sprague-Dawley rats.
  • To explore dose-dependent effects of naltrexone on organ development.

Main Methods:

  • Preweaning Sprague-Dawley rats were administered daily subcutaneous injections of naltrexone (1 or 50 mg/kg) or sterile water (control).
  • Organogenesis was assessed at weaning (Day 21) by measuring wet weight, dry weight, relative organ weight, and tissue water content across 10 organ systems.

Main Results:

  • Naltrexone administration significantly altered organ weights in a dose-dependent, sex-specific, and organ-specific manner.
  • Low-dose naltrexone (1 mg/kg) generally decreased organ weight, whereas high-dose naltrexone (50 mg/kg) increased it.
  • Observed changes in organ weight were attributed to alterations in dry weight (cellular content), not hydration status, and correlated with changes in body weight.

Conclusions:

  • Opioid receptor blockade influences organogenesis, affecting cellular content and overall growth proportionally to body weight changes.
  • The specific organ systems affected by naltrexone varied with dosage, highlighting complex regulatory roles of endogenous opioids in development.
  • These findings provide a basis for further research into the role of endogenous opioid systems in developmental biology.

Related Concept Videos